Cancer‐driven IgG promotes the development of prostate cancer though the SOX2‐CIgG pathway
The Prostate2020Vol. 80(13), pp. 1134–1144
Citations Over TimeTop 11% of 2020 papers
Abstract
Our data suggests that CIgG could be a driver of PCa development, and that targeting the SOX2-CIgG axis may therefore inhibit PCa development after ADT.
Related Papers
- → Application of Immunohistochemistry in Basic and Clinical Studies(2020)8 cited
- → Structural characterization of stem cell factors Oct4, Sox2, Nanog and Esrrb disordered domains, and a method to identify their phospho-dependent binding partners(2023)2 cited
- [Is standardization possible in immunohistochemical examination?].(1992)
- → Abstract 426: Sox2 expression in breast cancer stem cells: Possible mechanisms(2012)
- Comparison between the usage of immunohistochemistry autostainer and manual operation(2007)